Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example.
about
Building a new conceptual framework for receptor heteromersLooking for the role of cannabinoid receptor heteromers in striatal functionInternational Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesisMass spectrometry-based proteomics of human cannabinoid receptor 2: covalent cysteine 6.47(257)-ligand interaction affording megagonist receptor activation.Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens.Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis.Synthesis and biological evaluation of bivalent ligands for the cannabinoid 1 receptor.Toward the Development of Bivalent Ligand Probes of Cannabinoid CB1 and Orexin OX1 Receptor Heterodimers.Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?Physical and functional interaction between CB1 cannabinoid receptors and beta2-adrenoceptorsPsychopharmacology of the endocannabinoids: far beyond anandamide.Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors.Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signallingAT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II.Quinpirole elicits differential in vivo changes in the pre- and postsynaptic distributions of dopamine D₂ receptors in mouse striatum: relation to cannabinoid-1 (CB₁) receptor targeting.Ultrastructural evidence for synaptic contacts between cortical noradrenergic afferents and endocannabinoid-synthesizing post-synaptic neurons.Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal grayCannabinoid-1 receptors in the mouse ventral pallidum are targeted to axonal profiles expressing functionally opposed opioid peptides and contacting N-acylphosphatidylethanolamine-hydrolyzing phospholipase D terminals.The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55.Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritisDissociation of the pharmacological effects of THC by mTOR blockade.Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus.Emerging strategies for exploiting cannabinoid receptor agonists as medicines.Endocannabinoid-mediated control of synaptic transmission.Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevanceBasic neuroanatomy and neuropharmacology of cannabinoids.Signal transduction via cannabinoid receptors.New approaches in the design and development of cannabinoid receptor ligands: multifunctional and bivalent compounds.Rational Modification of the Biological Profile of GPCR Ligands through Combination with Other Biologically Active Moieties.Functional activity of the cannabinoid 1 receptor is not affected by opioid antagonists in the rat brain.C-terminal truncated cannabinoid receptor 1 coexpressed with G protein trimer in Sf9 cells exists in a precoupled state and shows constitutive activity.The endocannabinoid system controls key epileptogenic circuits in the hippocampus.An Update on Non-CB1, Non-CB2 Cannabinoid Related G-Protein-Coupled Receptors.Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics.Description of a bivalent cannabinoid ligand with hypophagic properties.CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity.Cocaine self-administration differentially modulates the expression of endogenous cannabinoid system-related proteins in the hippocampus of Lewis vs. Fischer 344 rats.Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats.
P2860
Q24644975-12DF3796-2B71-4E83-8865-A4151A0F0039Q24658338-F60D96D7-3771-4166-AA00-735D58BEADFEQ28298445-03AA545B-D924-470B-8874-E623543500F9Q28591542-ED5DD04B-7662-4946-AEF3-0013132A7CD5Q30406301-52BDFC40-B179-44F6-BE09-FE34C774185EQ30499463-8F74CEB4-603B-47DB-84A0-77868F54857DQ33664684-BA70B738-789F-4992-9D48-D619627F79AAQ33693780-07E1332C-BB7F-4299-AB68-9FA52546C88DQ33768567-14D5028B-D23D-406C-BF67-58CBD635E00CQ34098179-390A22EC-AD92-4383-AA5F-900266A912AEQ34098252-1A5C0AF5-70F8-497F-8C17-D6F8AE39AAA1Q34190754-169066B9-400C-43FE-83E0-25849DC923D8Q34574015-6FB69DCF-D77D-4F5B-A5BD-133DFE6CDB08Q34953430-74773A62-1641-425B-AABE-EA3B8F4B7C5AQ35048879-A55E3813-5A21-4FEC-B988-7B8982604F9DQ35882042-BE98B2DE-450A-4C3F-825A-00743365DFF0Q35972392-7D27549D-D4B3-4692-AA42-BBDA457B724DQ36007619-7665172C-6B85-41DC-8782-89B083060733Q36395211-E6D33895-9E35-4D6C-802F-A9D2C44BC869Q36492788-5111ADB3-5083-406D-8B21-7308736285AEQ36757024-AE9742C8-14C4-4D34-8225-ED7727CFF9AAQ36850581-5CAD06EC-35FD-4D11-AC3A-205FF8BEED8CQ37029175-802B88C1-36CA-47E9-8E22-E198B5E0EE09Q37230665-706CF5EB-DFBF-4BEE-9A73-A258F8EBF173Q37363621-080C415A-9D5A-45EE-925D-AE6BD622CB46Q37373710-2F316773-FBDD-478D-90C6-AAEE8FBC1D89Q37379456-5D15DB36-01CB-4F0C-9D92-55F05993ABCAQ37444802-EBA821D5-C35B-4C9F-8768-BC7957DEEE8BQ37617453-0A1BB2DF-BEB0-47D0-8BAC-7E71F398F19EQ38395251-72F82854-44A1-465F-9720-0E007A579696Q38458891-2690D0AD-A193-4845-B1AC-F94B5B62FBDCQ39401349-F0AE499D-1FD7-465A-89FF-74B6132F02E5Q42031399-EBAF0DFF-20E5-4E5C-ACC8-DF4F693D9A02Q42065383-AF833779-58A6-4231-82F9-BA924D1A4E65Q43075623-2C69AAA4-5471-465E-9B4B-B9A040F2FBB8Q44349574-8387833D-B0A3-430C-8C0E-C403C1C0AC3EQ45840317-80D9CE90-AB2A-4B09-BA51-42DEC5455486Q47134613-4157712F-8037-489E-A717-FD22B77D598AQ48109648-3CA52964-136F-4A59-82A7-3E82A276BE11Q48351216-1D5F7BE2-3179-4778-996C-37F6936EF809
P2860
Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example.
@ast
Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example.
@en
type
label
Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example.
@ast
Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example.
@en
prefLabel
Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example.
@ast
Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example.
@en
P921
P1476
Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example
@en
P2093
James Wager-Miller
Ruth Westenbroek
P356
10.1016/S0009-3084(02)00151-2
P50
P577
2002-12-01T00:00:00Z